Register Now
Course Information

Agenda

October 2, 2026
Dearborn, MI
All times in Eastern Time

7:50 am
Welcome and Announcements
Lars G. Svensson, MD, PhD
8:00 – 9:00 am

Session I – State of the Art Prevention and Management
Moderator: Leslie Cho, MD

Pushing the boundaries of lipid lowering: Large new trials to gene therapies
Ashish Sarraju, MD
Understanding the role of Lp(a) as a CV risk marker in the prevention of CV disease: New trials, when to refer
Leslie Cho, MD
Contemporary management and new trials in hypertension
Ashish Sarraju, MD
New Data on therapies for obesity, diabetes, kidney metabolic axis: Where research meets the clinic
Leslie Cho, MD
Era of modern preventive coronary imaging: Who, what when and why
Milind Desai, MD, MBA
Panel Discussion/Attendee Q&A
Session Faculty
9:10 am
Refreshments & Exhibit Break
9:30 – 10:40 am

Session II – Coronary Artery Disease
Moderator: Michael Tong, MD

Discussion about Inoca, Minoca testing and management
Khaled Ziada, MD
Decision making in coronary chronic total occlusion - Should we open?
Laura Young, MD
SCAD, anomalies and bridges: How to evaluate and when to refer
Khaled Ziada, MD
Robotic and Advanced CABG
TBD
Novel concepts in comprehensive surgical management of a patient with ischemic cardiomyopathy?
Michael Tong, MD
Panel Discussion/Attendee Q&A
Session Faculty
10:40 – 11:40 am

Session III – Mitral and Tricuspid Valve
Moderator: Samir Kapadia, MD

Modern concepts in multimodality imaging eval of mitral and tricuspid valve diseases
Rhonda Miyasaka, MD
Minimally invasive MV and TV surgical options
A. Marc Gillinov, MD
Management of complex mitral valve disease (MAC, radiation, infection etc.)
Shinya Unai, MD
Tricuspid and mitral structural interventions: When and how to intervene
Amar Krishnaswamy, MD
Panel Discussion/Attendee Q&A
Session Faculty
11:40 am
Lunch
12:40 – 2:00 pm

Session IV – Aortic Valve and aorta

Modern concepts in diagnosis of AS and aortopathies and emerging medical therapies
Milind Desai, MD, MBA
TAVR versus SAVR for AS: Latest data
Samir Kapadia, MD
Complex endocarditis surgery including reoperations
Shinya Unai, MD
Modern approaches to aortic valve surgery, including for AR, robotic, Ozaki
Eric Roselli, MD
Surgical management of patient with connective tissue disease and inherited aortopathies
TBD
Surgical management of thoracic aortopathies: Grafts to frozen elephant trunks
Eric Roselli, MD
Panel Discussion/Attendee Q&A
Session Faculty
2:00 pm
Exhibit Break
2:15 – 3:05 pm

Session V – Electrophysiology

A fib ablation: Latest data, new tricks and toys
TBD
LAA Closure: Who to refer and management after implantation
Oussama Wazni, MD
Ventricular ablation for arrhythmia
TBD
Panel Discussion/Attendee Q&A
Session Faculty
3:05 – 4:45 pm

Session VI – Heart Failure and Pericardial
Moderator: Amanda Vest, MBBS, MPH

HFrEF: Systems approach to GDMT implementation
Amanda Vest, MBBS, MPH
HFpEF: Medications, devices, and lifestyle management
Sean Bhattacharya, MD
Inherited cardiomyopathies: How to evaluate and when to refer
Amanda Vest, MBBS, MPH
Hypertrophic cardiomyopathy: current concepts and surgical outcomes
Milind Desai, MD, MBA
Management of advanced pericardial disease
Michael Tong, MD
Amyloid heart disease: Diagnosis and management. New trials and when to refer.
Mazen Hanna, MD
Is this advanced heart failure? When to refer for LVAD/transplant
Michael Tong, MD
Panel Discussion/Attendee Q&A
Session Faculty
4:35 pm
Closing Remarks
4:45 pm
Adjourn to networking reception

Back to top

November 6, 2026
Pittsburgh, PA
All times in Eastern Time

7:50 am
Welcome and Announcements
Lars G. Svensson, MD, PhD
Venkat R. Machiraju, MD
8:00 – 9:00 am

Session I – State of the Art Prevention and Management
Moderator: Leslie Cho, MD

Pushing the boundaries of lipid lowering: Large new trials to gene therapies
Vikas Sunder, MD
Understanding the role of Lp(a) as a CV risk marker in the prevention of CV disease: New trials, when to refer
Leslie Cho, MD
Contemporary management and new trials in hypertension
Vikas Sunder, MD
New Data on therapies for obesity, diabetes, kidney metabolic axis: Where research meets the clinic
Leslie Cho, MD
Era of modern preventive coronary imaging: Who, what when and why
Milind Desai, MD, MBA
Panel Discussion/Attendee Q&A (20 minutes)
Session Faculty
9:10 am
Refreshments & Exhibit Break
9:30 – 10:40 am

Session II – Coronary Artery Disease
Moderator: Khaled Ziada, MD

Discussion about Inoca, Minoca testing and management
Khaled Ziada, MD
Decision making in coronary chronic total occlusion - Should we open?
Laura Young, MD
SCAD, anomalies and bridges: How to evaluate and when to refer
Khaled Ziada, MD
Robotic and Advanced CABG
TBD
Novel concepts in comprehensive surgical management of a patient with ischemic cardiomyopathy?
Michael Tong, MD
Panel Discussion/Attendee Q&A (20 minutes)
Session Faculty
10:40 – 11:40 am

Session III – Mitral and Tricuspid Valve
Moderator: A. Marc Gillinov, MD

Modern concepts in multimodality imaging eval of mitral and tricuspid valve disease
Rhonda Miyasaka, MD
Minimally invasive MV and TV surgical options
A. Marc Gillinov, MD
Management of complex mitral valve disease (MAC, radiation, infection etc.)
Shinya Unai, MD
Tricuspid and mitral structural interventions: When and how to intervene
Samir Kapadia, MD
Panel Discussion/Attendee Q&A (20 minutes)
Session Faculty
11:40 am
Lunch
12:40 – 2:00 pm

Session IV – Aortic Valve and aorta
Moderator: Samir Kapadia, MD

Modern concepts in diagnosis of AS and aortopathies and emerging medical therapies
Milind Desai, MD, MBA
TAVR versus SAVR for AS: Latest data
Grant Reed, MD
Complex endocarditis surgery including reoperations
Shinya Unai, MD
Modern approaches to aortic valve surgery, including for AR, robotic, ozaki
Shinya Unai, MD
Surgical management of patient with connective tissue disease and inherited aortopathies
Lars G. Svensson, MD, PhD
Surgical management of thoracic aortopathies: Grafts to frozen elephant trunks
Xiaoying Lou, MD
Panel Discussion/Attendee Q&A
Session Faculty
2:00 pm
Exhibit Break
2:15 – 3:05 pm

Session V – Electrophysiology
Moderator: Mohamed Kanj, MD

A fib ablation: Latest data, new tricks and toys
Mohamed Kanj, MD
LAA Closure: Who to refer and management after implantation
Tyler Taigen, MD
Ventricular ablation for arrhythmia
Pasquale Santangeli, MD, PhD
Panel Discussion/Attendee Q&A
Session Faculty
3:05 – 4:45 pm

Session VI – Heart Failure and Pericardial
Moderator: Amanda Vest, MBBS, MPH

HFrEF: Systems approach to GDMT implementation
Amanda Vest, MBBS, MPH
HFpEF: Medications, devices, and lifestyle management
Sean Bhattacharya, MD
Inherited cardiomyopathies (dilated, restrictive, ARVC): How to evaluate and when to refer
Michael Hill, MD
Hypertrophic cardiomyopathy: current concepts and surgical outcomes
Milind Desai, MD, MBA
Amyloid heart disease: Diagnosis and management. New trials and when to refer.
Mazen Hanna, MD
Management of advanced pericardial disease
Allan Klein, MD
Is this advanced heart failure? When to refer for LVAD/transplant
Michael Tong, MD
Panel Discussion/Attendee Q&A
Session Faculty
4:35 pm
Closing Remarks
4:45 pm
Adjourn to networking reception

Back to top

November 13, 2026
Columbus, OH
All times in Eastern Time

7:50 am
Welcome and Announcements
Milind Desai, MD, MBA
8:00 – 9:00 am

Session I – State of the Art Prevention and Management
Moderator: Leslie Cho, MD

Pushing the boundaries of lipid lowering: Large new trials to gene therapies
Luke Laffin, MD
Understanding the role of Lp(a) as a CV risk marker in the prevention of CV disease: New trials, when to refer
Leslie Cho, MD
Contemporary management and new trials in hypertension
Luke Laffin, MD
New Data on therapies for obesity, diabetes, kidney metabolic axis: Where research meets the clinic
Leslie Cho, MD
Era of modern preventive coronary imaging: Who, what when and why
Milind Desai, MD, MBA
Panel Discussion/Attendee Q&A
Session Faculty
9:10 am
Refreshments & Exhibit Break
9:30 – 10:40 am

Session II – Coronary Artery Disease
Moderator: Faisal Bakaeen, MD

Discussion about Inoca, Minoca testing and management
TBD
Decision making in coronary chronic total occlusion - Should we open?
Laura Young, MD
SCAD, anomalies and bridges: How to evaluate and when to refer
TBD
Robotic and Advanced CABG
Faisal Bakaeen, MD
Novel concepts in comprehensive surgical management of a patient with ischemic cardiomyopathy?
Michael Tong, MD
Panel Discussion/Attendee Q&A
Session Faculty
10:40 – 11:40 am

Session III – Mitral and Tricuspid Valve
Moderator: Samir Kapadia, MD

Modern concepts in multimodality imaging eval of mitral and tricuspid valve disease
Serge Harb, MD
Minimally invasive MV and TV surgical options
A. Marc Gillinov, MD
Management of complex mitral valve disease (MAC, radiation, infection etc.)
Shinya Unai, MD
Tricuspid and mitral structural interventions: When and how to intervene
Samir Kapadia, MD
Panel Discussion/Attendee Q&A
Session Faculty
11:40 am
Lunch
12:40 – 2:00 pm

Session IV – Aortic Valve and aorta
Moderator: A. Marc Gillinov, MD

Modern concepts in diagnosis of AS and aortopathies and emerging medical therapies
Milind Desai, MD, MBA
TAVR versus SAVR for AS: Latest data
Amar Krishnaswamy, MD
Complex endocarditis surgery including reoperations
Faisal Bakaeen, MD
Modern approaches to aortic valve surgery, including for AR, robotic, Ozaki
Shinya Unai, MD
Surgical management of patient with connective tissue disease and inherited aortopathies
Xiaoying Lou, MD
Surgical management of thoracic aortopathies: Grafts to frozen elephant trunks
Shinya Unai, MD
Panel Discussion/Attendee Q&A
Session Faculty
2:00 pm
Exhibit Break
2:15 – 3:05 pm

Session V – Electrophysiology
Moderator: Oussama Wazni, MD

A fib ablation: Latest data, new tricks and toys
Oussama Wazni, MD
LAA Closure: Who to refer and management after implantation
Mohamed Kanj, MD
Ventricular ablation for arrhythmia
Pasquale Santangeli, MD, PhD
Panel Discussion/Attendee Q&A
Session Faculty
3:05 – 4:35 pm

Session VI – Heart Failure and Pericardial
Moderator: Amanda Vest, MBBS, MPH

HFrEF: Systems approach to GDMT implementation
Amanda Vest, MBBS, MPH
HFpEF: Medications, devices, and lifestyle management
Sean Bhattacharya, MD
Inherited cardiomyopathies (dilated, restrictive, ARVC): How to evaluate and when to refer
W.H. Wilson Tang, MD
Hypertrophic cardiomyopathy: current concepts and surgical outcomes
Milind Desai, MD, MBA
Management of advanced pericardial disease
Michael Tong, MD
Amyloid heart disease: Diagnosis and management. New trials and when to refer.
Mazen Hanna, MD
Is this advanced heart failure? When to refer for LVAD/transplant
Michael Tong, MD
Panel Discussion/Attendee Q&A
Session Faculty
4:35 pm
Closing Remarks
4:45 pm
Adjourn to networking reception

Back to top